Chronic Obstructive Pulmonary Disease (COPD), Chronic Heart Failure (CHF)
Conditions
Interventions
ADL-test before and after rehabilitation
Sponsors
Ciro+
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with COPD as a primary diagnosis according to the Global Initiative For Chronic Obstructive Pulmonary Lung Disease (GOLD) definition: ¡±Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients. Its pulmonary component is characterized by airflow limitation that is not fully reversible.The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lung to noxious particles or gases¡±. COPD is diagnosed by a chest physician. Patients with mild (GOLDI; FEV1/FVC<70% and FEV1¡Ý80% of predicted value) to very severe (GOLDIV; FEV1/FVC<70% and FEV1<30% of predicted value) COPD will be included in the study. OR 2. Patients with CHF as a primary diagnosis according to the American College of Cardiology and American Heart Association definition: ¡°Heart failure is a complex clinical syndrome that can resultfrom any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood¡±. CHF is diagnosed by a cardiologist. Patients with mild (NYHA class I) to severe (NYHA class IV) will be included in the study. 3. Clinically stable on the basis of clinical picture by chest physician or cardiologist. 4. Treated according to the current international guidelines. 5. Permission for voluntary participation. Patients will be asked after baseline assessment and have to sign an informed consent.
Exclusion criteria
Exclusion criteria: 1. Neuromuscular co-morbidities. Patients with neuromuscular co-morbidities can experience problems, not caused by COPD or CHF, during the performance of the activities of daily life. 2. Lack of motivation for voluntary participation in this study. 3. Patients with long-term oxygen therapy use will be excluded for measurements of metabolic load.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference in ventilation and oxygen uptake during the performance of ADL before and after rehabilitation. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Difference in physical activity 2.Difference in heart rate 3.Difference in time to accomplish the ADLs 4.Difference in Borg symptom scores after the performance of ADLs 5.Differences in COPM (patients scores on performance and satisfaction) | — |
Contacts
Public ContactMartijn A. Spruit
Program Development Centre CIRO+, centre of expertise for chronic organ failure Hornerheide 1
Outcome results
None listed